Clinical Trials Directory

Trials / Conditions / Neuroendocrine Tumor Grade 2

Neuroendocrine Tumor Grade 2

8 registered clinical trials studyying Neuroendocrine Tumor Grade 2 — 5 currently recruiting.

StatusTrialSponsorPhase
TerminatedComparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Ne
NCT05987176
Imperial College LondonPhase 2
RecruitingAbsorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Tr
NCT06855095
The Netherlands Cancer InstitutePhase 2 / Phase 3
Recruiting177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
NCT06395402
University of IowaPhase 2
RecruitingEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
NCT06472388
AC Camargo Cancer CenterPhase 2
Active Not RecruitingA Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
NCT06148636
David BushnellEARLY_Phase 1
Active Not RecruitingA First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
NCT05111509
Yusuf MendaEARLY_Phase 1
RecruitingCapTemY90 for Grade 2/3 NET Liver Metastases
NCT04339036
Abramson Cancer Center at Penn MedicinePhase 2
RecruitingRediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
NCT04464122
University of Roma La Sapienza—